The role of passive immunization in the age of SARS-CoV-2: an update.
Bridge therapy
Convalescent plasma
Covid-19
High risk
Immunology
Intensive care unit
Respiratory failure
Journal
European journal of medical research
ISSN: 2047-783X
Titre abrégé: Eur J Med Res
Pays: England
ID NLM: 9517857
Informations de publication
Date de publication:
13 May 2020
13 May 2020
Historique:
received:
22
04
2020
accepted:
30
04
2020
entrez:
15
5
2020
pubmed:
15
5
2020
medline:
16
5
2020
Statut:
epublish
Résumé
The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.
Identifiants
pubmed: 32404189
doi: 10.1186/s40001-020-00414-5
pii: 10.1186/s40001-020-00414-5
pmc: PMC7220618
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Commentaires et corrections
Type : ErratumIn
Références
J Clin Invest. 2020 Jun 1;130(6):2757-2765
pubmed: 32254064
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Nat Med. 2020 Apr;26(4):453-455
pubmed: 32284614
Crit Care. 2020 Apr 2;24(1):128
pubmed: 32241301
Vox Sang. 2020 Aug;115(6):488-494
pubmed: 32240545
Am J Transplant. 2020 Jul;20(7):1809-1818
pubmed: 32282982
J Cell Commun Signal. 2011 Jun;5(2):145-56
pubmed: 21484192
J Korean Med Sci. 2020 Apr 13;35(14):e149
pubmed: 32281317
J Med Virol. 2020 Oct;92(10):1890-1901
pubmed: 32293713
Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496
pubmed: 32253318
Radiother Oncol. 2020 Jun;147:100-102
pubmed: 32259751
Nat Rev Immunol. 2020 May;20(5):277
pubmed: 32249845
JAMA Neurol. 2020 Jun 1;77(6):683-690
pubmed: 32275288
Ann Oncol. 2020 Jul;31(7):894-901
pubmed: 32224151
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Lancet Oncol. 2020 Apr;21(4):e181
pubmed: 32142621
F1000Res. 2020 Jan 31;9:72
pubmed: 32117569
JAMA. 2020 Apr 28;323(16):1582-1589
pubmed: 32219428
BMJ. 2020 Mar 26;368:m1256
pubmed: 32217555
Science. 2002 Apr 12;296(5566):301-5
pubmed: 11951032
Nat Rev Immunol. 2020 May;20(5):277
pubmed: 32249847
Am J Transplant. 2020 Jul;20(7):1916-1921
pubmed: 32282986
Lancet Infect Dis. 2020 Apr;20(4):398-400
pubmed: 32113510
J Leukoc Biol. 2007 Mar;81(3):584-92
pubmed: 17135573
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
JAMA. 2020 Apr 28;323(16):1561-1562
pubmed: 32219429
Brain Behav Immun. 2009 May;23(4):527-34
pubmed: 19217939